Literature DB >> 29190244

EVALUATION OF OBSTRUCTIVE SLEEP APNEA SYNDROME AS A RISK FACTOR FOR DIABETIC MACULAR EDEMA IN PATIENTS WITH TYPE II DIABETES.

Anne-Laure Vié1, Laurent Kodjikian2, Emilie Agard, Nicolas Voirin3, Hussam El Chehab4, Philippe Denis2, Olivier Coste4, Corinne Dot4.   

Abstract

PURPOSE: To evaluate the association between obstructive sleep apnea and diabetic macular edema (DME) in patients with Type II diabetes, using the apnea-hypopnea index and other nocturnal hypoxemia parameters.
METHODS: This cross-sectional, case-control study included 99 patients with Type II diabetes: the first group included patients with DME (DME+ group) and the second patients without DME (DME- group). Polysomnography was performed in all patients. The two groups were compared, and the risk factors were studied using logistic regression.
RESULTS: The DME+ group comprised 38 patients, and the DME- group comprised 61 patients, aged a mean 68.8 years and 66.3 years (P = 0.27), respectively; mean body mass index was 29.7 and 30.9 (P = 0.16), respectively. The mean apnea-hypopnea index was significantly higher in the DME+ group (43.95 [13.5-87.3]) than in the DME- group (35.18 [3.55-90.7]) (P = 0.034). Patients with DME had more severe obstructive sleep apnea (apnea-hypopnea index >30) than the others: 71% versus 50.8% (P = 0.049). Cumulative time of SPO2 below 90% (CT90%) was independently associated with DME after adjusting for confounding factors, whereas there was no difference between the oxygen desaturation index and minimum O2 saturation.
CONCLUSION: Severe obstructive sleep apnea (apnea-hypopnea index >30) and parameters of nocturnal hypoxemia (cumulative time of SPO2 below 90%) are associated with DME.

Entities:  

Mesh:

Year:  2019        PMID: 29190244     DOI: 10.1097/IAE.0000000000001954

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  7 in total

Review 1.  Statement of the German Ophthalmological Society, the German Retina Society, and the Professional Association of Ophthalmologists in Germany on treatment of diabetic macular edema : Dated August 2019.

Authors: 
Journal:  Ophthalmologe       Date:  2021-01       Impact factor: 1.059

2.  Prevalence of and risk factors for diabetic macular edema in a northeastern Chinese population.

Authors:  Zhong Lin; Feng-Hua Wang; Liang Wen; Yu Wang; Dong Li; Xiao-Xia Ding; Yu Dou; Gang Zhai; Yuan-Bo Liang
Journal:  Int J Ophthalmol       Date:  2022-02-18       Impact factor: 1.779

3.  Nomogram-based prediction of clinically significant macular edema in diabetes mellitus patients.

Authors:  Zijing Li; Xiaowen Deng; Lijun Zhou; Tu Lu; Yuqing Lan; Chenjin Jin
Journal:  Acta Diabetol       Date:  2022-06-24       Impact factor: 4.087

4.  Screening for obstructive sleep apnea in a diabetic retinopathy clinic in a tertiary care center.

Authors:  Rakesh Kaswan; Reema Bansal; Deeksha Katoch; Mohit Dogra; Ramandeep Singh; Vishali Gupta; Mangat R Dogra; Sandeep Bansal
Journal:  Indian J Ophthalmol       Date:  2021-11       Impact factor: 1.848

5.  Diabetic macular edema treatment guidelines in India: All India Ophthalmological Society Diabetic Retinopathy Task Force and Vitreoretinal Society of India consensus statement.

Authors:  Sneha Giridhar; Lalit Verma; Anand Rajendran; Muna Bhende; Mallika Goyal; Kim Ramasamy; R Padmaja; Sundaram Natarajan; Mahesh Shanmugam Palanivelu; Rajiv Raman; Sobha Sivaprasad
Journal:  Indian J Ophthalmol       Date:  2021-11       Impact factor: 1.848

6.  Examining the Relationship Between Diabetic Macular Edema, and Obstructive Sleep Apnea.

Authors:  Qayim Kaba; Felicia Tai; Ahmad Al-Awadi; Sohel Somani
Journal:  Clin Ophthalmol       Date:  2022-04-21

Review 7.  Sleep and eye disease: A review.

Authors:  Samantha S Y Lee; Vinay K Nilagiri; David A Mackey
Journal:  Clin Exp Ophthalmol       Date:  2022-03-16       Impact factor: 4.383

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.